eClinical Solutions to Share Insights on AI-Driven Clinical Trial Productivity at Multiple Industry Events

eClinical Solutions to Share Insights on AI-Driven Clinical Trial Productivity at Multiple Industry Events

Boston, June 12, 2024 — eClinical Solutions, a global provider of digital clinical software and services, is set to participate in several influential industry events this summer. The company aims to demonstrate its expertise in clinical data transformation through its elluminate® platform and biometrics services, amidst a rapid industry pivot towards AI and machine learning (ML).

With an increasing number of pharmaceutical companies looking to leverage AI/ML technologies, eClinical Solutions’ upcoming engagements come at a crucial time. According to the company’s 2024 Industry Outlook survey, while 53% of respondents believe AI/ML will significantly enhance efficiency within the year, only 7% have implemented these technologies at scale. This discrepancy underscores the urgency to move from theoretical benefits to tangible implementation, transforming data and unlocking AI-driven value.

Raj Indupuri, co-founder and CEO of eClinical Solutions, will be a key participant in the discussions. He is scheduled to join a panel at the Citeline roundtable in San Diego on June 18. The session, titled “Holistic Clinical Data Transformation: Setting the Stage for AI-driven Productivity,” will delve into strategic approaches for integrating emerging technologies in clinical research. The panel, moderated by Citeline’s Barnaby Pickering, will include industry professionals such as Elisa Cascade from Advarra, Dr. Nimita Limaye of IDC Health Insights, Karen Correa from Takeda, and Jeffrey Meckler of Indaptus Therapeutics.

In addition to the Citeline roundtable, eClinical Solutions will participate in several other key events:

• June 16-20: At the DIA’s 60th Annual Global Meeting in San Diego, CA, eClinical Solutions will exhibit at booth #1220. The team plans to engage attendees in discussions about leveraging the elluminate® platform to maximise AI’s transformative potential.

• June 24-25: The company will sponsor the 3rd Annual ACDM AI Symposium in Basel, Switzerland. eClinical will also host a demo session on June 25, focusing on AI’s role in enhancing data management for clinical trials.

• July 9-10: At the 13th Annual Clinical Trials in Oncology East Coast Conference in Boston, MA, Jason Konn, a solutions consultant at eClinical, will lead a technology spotlight session titled “Oversight for All: Achieve Data Transparency with elluminate®” on July 9.

Indupuri expressed his enthusiasm for the company’s packed summer schedule. “We’re thrilled to participate in these premier industry events and connect with other leaders driving innovation in clinical trials, especially during this rapidly evolving surge of tech and AI advancement for life sciences,” he stated. He emphasised that these engagements highlight eClinical’s commitment to fostering innovation and adopting new technologies to streamline clinical trial processes.

The company’s active participation in these events further underscores its role in transforming modern digital trials. eClinical Solutions aims to help clients accelerate timelines and achieve scientific advancements by providing accurate, timely data insights for better decision-making. This, in turn, aids biopharma researchers in managing trial complexity more efficiently and scaling their operations with existing resources.

The series of engagements will also feature discussions on leveraging AI to meet the industry’s increasing demands for efficiency. This dialogue is expected to help bridge the gap between AI’s theoretical potential and practical application, enabling faster adoption across clinical trials.

For more detailed information on the events, eClinical Solutions’ planned engagements, and their broader impact on the industry, visit their website.